Evidence map›Paper›PMID 37137852›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Expression and clinical significance of plasma methylated SEPT 9 gene in patients with primary liver cancer].

N He, G Feng, F N Zhang, S Hao, R Li, Z Q Zhao, Y W Tian, H L Yan

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

N HeDepartment of Gastroenterology, The First Affiliated Hospital of Xi'an Medical University, Xi 'an 710006, China.
G FengInstitute of General Medicine, Xi 'an Medical University, Xi'an 710077, China.
F N ZhangDepartment of Gastroenterology, The First Affiliated Hospital of Xi'an Medical University, Xi 'an 710006, China.
S HaoXi 'an Medical College, Xi 'an 710077, China.
R LiXi 'an Medical College, Xi 'an 710077, China.
Z Q ZhaoXi 'an Medical College, Xi 'an 710077, China.
Y W TianXi 'an Medical College, Xi 'an 710077, China.
H L YanDepartment of Gastroenterology, The First Affiliated Hospital of Xi'an Medical University, Xi 'an 710006, China.
Xi'an Medical University · CN

Funding

Natural Science Foundation of Shaanxi Province 2021JM-493Shaanxi Fundamental Science Research Project for Chemistry Biology 22JHQ091Special Research Fund of Youan Medical Alliance for the Liver and Infectious Diseases LM202003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorLiver NeoplasmsSeptinsalpha-FetoproteinsBlood Chemical AnalysisDNA MethylationHumansLiver CirrhosisSensitivity and Specificityalpha-FetoproteinsBiomarkers, TumorSEPTIN9 protein, humanSeptinsClinical significanceDiagnosisMethylationPrimary liver cancerSEPT9 DNA

Identifiers

PMID37137852
PMCPMC12814391
OpenAlexW4368356607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.